JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 53 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,397,000 | +54.7% | 275,506 | +80.5% | 0.01% | +42.9% |
| Q1 2018 | $1,549,000 | +373.7% | 152,613 | +126.9% | 0.01% | +600.0% |
| Q4 2017 | $327,000 | +71.2% | 67,269 | +59.9% | 0.00% | 0.0% |
| Q3 2017 | $191,000 | -9.5% | 42,068 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $211,000 | +7.7% | 41,978 | +2.3% | 0.00% | 0.0% |
| Q1 2017 | $196,000 | -9.7% | 41,037 | +6.6% | 0.00% | 0.0% |
| Q4 2016 | $217,000 | -10.3% | 38,493 | -11.4% | 0.00% | 0.0% |
| Q3 2016 | $242,000 | -50.5% | 43,430 | -37.8% | 0.00% | -50.0% |
| Q2 2016 | $489,000 | -43.5% | 69,810 | -46.7% | 0.00% | -50.0% |
| Q1 2016 | $866,000 | -46.0% | 130,858 | -16.0% | 0.00% | -50.0% |
| Q4 2015 | $1,604,000 | +50.5% | 155,747 | +72.0% | 0.01% | +33.3% |
| Q3 2015 | $1,066,000 | +5230.0% | 90,529 | +3945.1% | 0.01% | – |
| Q2 2015 | $20,000 | – | 2,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 388,132 | $1,844,000 | 0.38% |
| Krensavage Asset Management, LLC | 243,128 | $1,155,000 | 0.37% |
| ALGERT GLOBAL LLC | 108,315 | $514,000 | 0.14% |
| HEARTLAND ADVISORS INC | 400,000 | $1,900,000 | 0.12% |
| AWM Investment Company, Inc. | 200,000 | $950,000 | 0.09% |
| TFS CAPITAL LLC | 31,619 | $150,000 | 0.05% |
| GLOBEFLEX CAPITAL L P | 20,012 | $95,000 | 0.02% |
| Spark Investment Management LLC | 45,100 | $214,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,200 | $856,000 | 0.01% |
| Acrospire Investment Management LLC | 1,605 | $8,000 | 0.01% |